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Abstract: 
Using a sample of 28 sub-Saharan African countries during the period of 2000-2010, this 
paper examines the effect of health aid on health outcomes. After taking into account the 
endogeneity and using the instrumental variable approach, the results reveal that health aid 
improves health outcomes in sub-Saharan African countries. More specifically, for each 
additional unit of health aid, life expectancy increases by 0.14, prevalence of HIV decreases 
by 0.05 and infant mortality decrease by 0.17. This effect operates mainly through the 
improvement of primary completion rate of female. However, the magnitude of the effects is 
too small if African countries would like to achieve MDGs through additional health aid. 
Furthermore, the Oaxaca-Blinder decomposition indicates that differences in terms of the 
amount of health aid received do not explain the health outcomes gap between post conflict 
countries and stable countries. The relevant variables are governance and the female primary 
completion rate. The policy implications of the paper are further discussed. 
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INTRODUCTION 
 
Studies undertaken on health care in developing countries evoked several arguments. First of 
all, the health status of the populations is a major preoccupation as it determines the level of 
productivity of the labor force and contributes to growth as well as to poverty reduction 
(Bloom et al., 2004; Carstensen & Gundlach, 2006; Weil, 2007). The key role of health as 
input for development has been reaffirmed at the international level, as proofed by the 
Millennium Development Goals (MDGs). Indeed, three out of the eight objectives of the 
MDGs are centered directly on health (child mortality reduction, improve maternal health and 
fight against HIV/AIDS, malaria and other disease). Secondly, the paradox that developing 
countries face relies on the size of their needs in the access to health care services in a context 
of severe financial constraints. Foreign aid remains one of the main sources of the external 
financing of health care services in developing countries in general and in Africa in particular 
(Ebeke & Drabo, 2011).  This could be explained by the widely shared belief that foreign aid 
improves health outcomes in developing countries by relaxing resource constraints and 
directly improving health service delivery. 
According to some researchers, Sub-Saharan Africa (SSA) has been a major recipient of 
health aid for decades (Gomanee et al., 2005a ; Williamson, 2008), yet this part of the world 
has exhibited poor health performance. A variety of factors have contributed to poor health 
indicators in SSA, including a lack of political will to put in place major reforms (e.g. 
improving governance, tackling corruption) and a lack of resources for financing the health 
sector. 
Despite the recent global economic and financial crisis, gross ODA (Official Development 
Assistance) aid disbursement for health in SSA, has increased from one billion in 2000 to four 
billion in 2009 (World Bank, 2011).  SSA is also making progress in the health sector. 
Maternal mortality rates have decreased from 777 deaths per 100,000 births in the 1990s to 
588 per 100,000 in 2008. Similarly, the national under-five mortality rate has also dropped 
from 147 in 2000 to 118 in 2009. Life expectancy has improved and gone up from 52 in 1990 
to 55 in 2009 (World Bank, 2011). In spite of these improvements, SSA still has a long way 
to go. Both maternal and under-five mortality rates should decrease by half in order to meet 
the fourth and fifth objectives of MDGs by 20152. SSA has the highest HIV prevalence rate of 
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5%, followed by the Caribbean (1.1%), and Eastern Europe and Central Asia (0.8%) [Youde, 
2010]. 
Despite the empirical literature considering the effect of foreign aid on growth, there is little 
disaggregated evidence on how overall foreign aid affects health, as well as how health aid 
affects health outcomes. Moreover within the available literature (Chauvet et al., 2008; 
Williamson, 2008, Ebeke & Drabo, 2011; Mishra and Newhouse, 2009; Masud & Yontcheva, 
2005; Bell & Fink, 2005), there is no agreement or strong evidence of the effect of health aid 
on health outcomes. In fact, while Ebeke & Drabo (2011), Mishra & Newhouse (2009) find a 
strong positive effect of health aid, Williamson (2008), Wilson et al. (2008) do not observe 
any significant effect. One of the major concern in this literature is about the wide variety of 
health indicators used, ranging from life expectancy, infant mortality (Williamson, 2008; 
Wilson et al., 2008; Mishra & Newhouse, 2009) to access to health care services (Ebeke & 
Drabo, 2011). This makes difficult the comparison across studies. Furthermore, most of the 
studies make use of a full sample of developing countries. Although they control for country 
and regional effect, this kind of studies are not able to fully account for regional specificity as 
it is the case for SSA countries. Another issue is related to the fact that there is almost no 
paper accounting for the vulnerability of countries. Yet, this is important because, as stated by 
Collier and Hoeffler (2002), Collier et al (2010), aid could be most effective in post conflict 
situation which is characterized by a high level of vulnerability. Thus it is important to 
investigate whether observed health outcomes gap between post conflict countries and stable 
ones be explained in terms of the differences in the amount of aid received. Finally, in the 
literature, both direct and indirect effects of foreign aid on the health indicators are not 
considered. This call for more investigation on the effect of health aid on the health 
improvement, mostly in SSA where the standards of living are very low. Thus the overall 
objective of the paper is to examine the effect of health aid on health outcomes in SSA. 
The contribution of this paper is twofold. First the effectiveness of health aid in SSA is 
assessed while accounting for both direct and indirect impacts on the health indicators namely 
infant mortality, life expectancy and the prevalence of HIV AIDS. These indicators represent 
the main priorities of health system in SSA countries; and related data are available for a large 
set of countries. Second, the study leans upon the hypothesis that the effect of health aid on 
health indicators may differs according to the political environment. Specifically, we evaluate 
the contribution of differences in the amount of health aid received in explaining the health 
outcomes gap between post conflict states and stable states. For this purpose, we make use of 
the well know Oaxaca-Blinder decomposition which to our knowledge has not yet been used 
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in such macro analysis. Following Collier and Hoeffler (2002), post conflict countries are 
defined as countries having known civil war in the two last decades and that record some 
pocket of rebellion3. Our hypothesis comes from the fact that in African post conflict 
countries, there is more challenges of health service delivery. Post conflict countries may 
present bad indicators of health than countries in normal situation, due to the complexities of 
the sector, poor infrastructure, security issues, and the need to implement small-scale 
operations. The study concerns 28 SSA countries during the period 2000-2010. 
The rest of the paper is organized as follows. Section 2 provides a literature review with 
emphasis on the recent literature. Section 3 outlines the empirical model and describes the 
data. Section 4 presents the results; section 5 discusses some robustness check while Section 6 
concludes. 
 
2. LITERATURE REVIEW 
 
This section provides a review of the available literature on the relationship between foreign 
aid and health. The question of foreign aid impact on health outcome is highly controversial 
and excites polarized opinions. There are two competing hypothesis about how foreign aid 
affects health income in recipient countries. The first hypothesis is optimistic about aid impact 
on health. According to this view, foreign aid can have a positive effect on developing 
countries’ health indicators by improving them (Drabo & Ebeke, 2011; Mishra & Newhouse, 
2009; Chauvet et al., 2008). The second hypothesis is pessimistic. According to this view, aid 
is not only unable to promote health in recipient nations, but often has the opposite effect 
(Wilson et al., 2009; Williamson, 2008). 
In the first view, foreign aid is needed to enhance the quality of the health’s indicators. In this 
vein, Chauvet et al. (2008) analyzed the respective impact of aid and remittances on human 
development as measured by infant and child mortality rates with a panel data on a sample of 
109 developing countries, and cross-country quintile-level data on a sample of 47 developing 
countries. Their results suggest that health aid significantly improve child health outcomes. 
The impact of health aid is non-linear, though, suggesting that aid to the health sector is more 
effective in the poorest countries. Recent work by Ebeke & Drabo (2011) finds that 
remittances, health aid and public spending are important determinants of access to health 
services in recipients’ countries. In the same vein, Mishra & Newhouse (2009) examine the 
relationship between health aid and infant mortality, using data from 118 countries between 
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1973 and 2004. They find that increased health aid is associated with a statistically significant 
reduction in infant mortality. The estimated effect of doubling health aid is a 2% reduction in 
infant mortality rates, which is small in light to the desired goals of the MDGs. In contrast, 
they fail to find concrete evidence for a statistically significant effect of overall aid in 
reducing infant mortality. The results are consistent with suggestive evidence that unlike 
overall aid, health aid is associated with a statistically significant rise in health spending. The 
estimated effect of health aid on infant mortality should be mitigated because the health aid 
data are likely to suffer from underreporting. 
Masud & Yontcheva (2005) assessed the effectiveness of foreign aid in reducing poverty 
through its impact on human development indicators. Their results show that NGOs aid 
reduces infant mortality and does so more effectively than official bilateral aid. 
The opposite view is that foreign aid is ineffective to improve health indicators in recipient 
countries. In this line, Wilson et al. (2009) find that the extensive funds going to the health 
sector aid basically have no impact on the level of mortality across countries. In short, health 
aid is not able to meet health needs, and health sector aid has had little visible effect on 
improvements in mortality. Likewise, Williamson (2008) finds a negligible impact of health 
sector aid on a variety of health outcomes, including Infant mortality, life expectancy and 
death rate. Kosack & Tobin (2006) find no impact of development assistance on infant 
mortality or life expectancy. Negative findings are not universal; Goomanee et al. (2005b) 
find that total aid flows (as a percentage of GDP) do lead to higher levels of aggregate welfare 
(as measured by the Human Development Index (HDI), though the effects are weaker for 
infant mortality. Kosack (2003) argues that development aid has a positive effect on HDI 
when the country is a democracy, but a negative effect in an autocracy. 
Very little is known, however, about health aid effectiveness at the sub-aggregate level, such 
as the effect of projects targeted at particular health problems or at particular communities. 
White (2003) looks at specific health interventions in Bangladesh and finds that health 
outcomes are not related to health aid, but are related to aid in other sectors. From a 15 year, 
carefully controlled study in rural Gambia, Hill (2000) reports that both villages with 
assistance in providing primary care and those without assistance experience a decline in child 
health. Some works show the effectiveness of some types of targeted aid. Du Lou et al. 
(1995), for instance, evaluate a vaccination program in Senegal and find, unsurprisingly, a 
negative relationship between vaccination rates and child mortality. 
Despite the empirical literature considering the effect of foreign aid on health, systematic 
evidence that aid improves HIV prevalence rates is surprisingly scarce. To the best of our 
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knowledge, the paper of Youde (2010) is the first empirical study to examine the effect of 
health aid on adult HIV prevalence rates. He finds that there exists a negative statistically 
significant relationship between adult HIV prevalence rates and the amount of foreign aid. 
In the nutshell, most of the previous studies on the effect of foreign aid on health have mainly 
focused on large sample of developing countries. For the best of our knowledge, there is no 
study which focused exclusively on a sample of SSA. Though, Africa continues to trail the 
rest of the world on human development indicators including life expectancy; infant 
mortality; undernourishment; school enrollment; and the incidence of HIV/AIDS, malaria, 
and tuberculosis. The international aid lobby advocates more foreign aid and greater debt 
relief for Africa as impetus for development. 
This study is a contribution to the clarification of the debate on the effects of Foreign Aid on 
Health indicators. It makes difference between African post conflict countries and countries in 
normal environment. 
3. EMPIRICAL FRAMEWORK 
In order to explore the effectiveness of health aid in health sector, we follow the bulk of the 
previous literature, notably Ebeke & Drabo (2011), Youde, (2010), Mishra & Newhouse 
(2009) and Williamson (2008). The uniqueness of our investigation framework lies on two 
points. 1)  In addition to assessing the direct effect of health aid as it is done in the previous 
literature; we account for transmission channel (indirect effects) between health aid and health 
outcomes. 2) We use the well-known decomposition of Oaxaca Blinder in order to evaluate 
the contribution of health aid in explaining the health outcome gap between post conflict 
states and stable states. 
3.1. Direct effect of health aid in sub-saharan African countries 
3.1.1 Ordinary least square 
We begin by running a simple OLS fixed effect estimates. Our baseline specification is as 
follows:  
1it it it i t itHealth haid Xθ β α τ ε′= + + + +                                                  (1) 
Where itHealth   refers to health indicator for country  at time t, ithaid is health aid per capita 
for country  at time t  and X is a set of control variables. The main variable of interest is 
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foreign aid to the health sector. This is the aggregate total for general health and basic health. 
It includes health policy and administrative management; medical education/training; medical 
research and medical services. Related data are drawn from the World Bank (ADI4, 2011). 
This is the more recent database made available by the World Bank for African countries. 
Data are collected for 28 SSA countries over the period of 2000-2010 for which information 
are available. In fact the less availability of data specific to African states, notably for various 
indicators of health justifies the short time period of the study. Moreover, using the most 
recent data permit to better appreciate the major progress of African states toward the MDGs5. 
Data are yearly. This could raise the issue of stationarity. Though, it is not the case because 
the maximum years of observations per country stand at 4. Likewise, most of the unit root 
tests in panel data cannot be handled with a number of years lower than 9 (this is for instance 
the case for the Im-Pesaran-Shin test). Finally, one could use a five years average, but we lose 
a high number of observations and it becomes difficult to run a regression. 
Three main health indicators are used to capture the overall quality of health in each sub-
Saharan country. These include life expectancy, HIV prevalence and infant mortality at birth. 
Life expectancy at birth indicates the number of years a newborn infant would live if 
prevailing patterns of mortality at the time of its birth were to stay the same throughout its 
life. Prevalence of HIV refers to the percentage of people aged from 15 to 49 years that are 
infected with HIV. Infant mortality rate is the number of infants dying before reaching one 
year of age, per 1,000 live births in a given year. All these variables are taken from the World 
Bank (ADI, 2011). Following Williamson (2008), we expect a positive impact of health aid 
on life expectancy, while this effect should be negative for infant mortality (see also Mishra & 
Newhouse, 2009, Wagstaff, 2011). Furthermore, we expect that the flow of health aid in 
health sector may lead to a decline in the HIV prevalence as far as more funds are spent for 
the prevention of HIV infection. 
A full set of control variables are included in the model: the urban population in percentage of 
the total population, an index of governance to control for changes in institutional 
environment (see Williamson, 2008), lagged variable of GDP6 per capita constant 2000 US$, 
Gross fixed capital formation, school enrollment rate in primary, female primary completion 
rate, lagged variable of fertility rate, inflation (CPI) and labor force. Except governance for 
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which data are from the World Wide Governance Indicator of the World Bank7, all the 
aforementioned data are from World Bank (ADI, 2011). Using the GDP per capita, we control 
for the level of development as far as high level of development may be correlated with high 
health expenditure (Acemoglu & Johnson, 2006). Besides all education variable should 
positively impact life expectancy and negatively affect infant mortality and HIV prevalence.  
The respective effect of fertility and urban population are mixed (see Williamson, 2008; 
Kalemli-Ozcan & Turan, 2011)8. As far as governance is concerned, one expects a positive 
effect on life expectancy and a negative effect on HIV prevalence and infant mortality. This 
could be explained by the fact that countries with high level of governance attract more aid 
which is also better managed (Fielding, 2011).  
It would be appropriate to include in the model other control variable such as the number of 
physicians. However, this variable does not have enough observation over the short period 
retained for this paper. Moreover, the fact that the marginal effect of health aid on life 
expectancy should decrease as the life expectancy increase raises the issue of non linearity. 
Although we address a short time relationship, the squared of health aid is included in 
equation (1), for the purpose of robustness check. Table 1 presents the descriptive statistics of 
variables used in the regression while Table 2 displays the OLS fixed effects estimates (to be 
discussed in the section devoted to results). 
 
     [Insert Table 1 about here] 
 
3.1.2. Instrumental variable estimates 
The main drawback behind OLS is that OLS results are biased if aid is correlated with the 
unobserved component of health indicator (life expectancy, infant mortality or prevalence of 
HIV). For instance, if countries receive more health aid as infant mortality increases, the 
beneficial effect of aid would be underestimated (Mishra & Newhouse, 2009; Ebeke & Drabo, 
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( ) ( )
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governance governance
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−
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 Fertility is mainly used for robustness check. However in order to account for its potential endogeneity 
(Kalemli-Ozcan & Turan, 2011), one makes use of the lagged variable of fertility. 
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2011). Another potential source of bias is measurement error. Since the health aid data are 
reported by donors, any measurement error is likely to be correlated with the characteristics of 
the recipient country, which would imply that any beneficial effect of aid would be further 
underestimated (Mishra & Newhouse, 2009).. OLS results could be therefore biased toward 
zero and they can underestimate the ‘true’ impact. To deal with the endogeneity bias, one 
makes use of an instrumental variable approach.  
Four instruments are used following the instrumentation procedure initiated by Tavarez 
(2003) and recently revisited by Brun et al. (2006), Chauvet et al. (2008) and Ebeke & Drabo 
(2011).  
The idea behind this procedure is that the level of foreign aid received by a given country 
from each one of the major donors is related to the various aspects of the proximity 
(geographical and cultural proximities) between the considered developing country and the 
donors (Ebeke & Drabo, 2011). In this vein, we make use of 1) the amount of aid given by 
each donor weighted by an indicator of common language between recipient country and 
donors. 2) the amount of aid given by each donor weighted by an indicator of common 
dominant religion in both recipient and donor country. 3) Conventional deficit in the donor 
country weighted by the inverse geographical distance between the recipient and the donor 
country. 4) Global donation weighted by the inverse geographical distance between the 
recipient and the donor country. Data related to these instruments are taken from Ebeke & 
Drabo (2011). 
In order to check the quality (to ensure that instruments are not weak) of the considered 
instruments, we rely on the Stock and Yogo (2005) weak instrument test. Results are reported 
in each table of result according to the specification adopted. 
 
3.1.3. Contribution of Health aid to the health outcome gap between post conflict states 
and stable states 
This subsection is built on the idea that aid could be more effective in post conflict countries 
than in stable ones (see Collier & Hoeffler, 2002; Collier et al, 2010).  
The rationale behind this statement relies upon the fact that during the first few years of 
peace, the absorptive capacity of aid is about twice what it is usually. Moreover, as 
highlighted by Collier et al (2010), aid stabilizes post-conflict environment and increase the 
probability of the success of aid projects. Following this view, we want to investigate whether 
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differences in the amount of aid received, between post conflict countries and stable countries 
could explain their health outcome gap.  
This approach differs to the usual methodology where an interaction variable between aid and 
a dummy of conflict (1 for post conflict countries and 0 otherwise) is included in the 
regression. In fact, using this methodology, we are able to evaluate the contribution of each 
explanatory variable to the gap (in terms of health outcomes) between post conflict countries 
and stable countries.9 Let us recall that post conflict countries are defined as countries having 
known civil war in the two last decades and that record some pocket of rebellion. For the sake 
of simplicity, we adopt a general presentation following Yun (2005). Suppose that we have a 
variable of health which is a function of a linear combination of independent variables such 
that: 
 
( )h F Vψ=
                                                                                                                 
(2) 
F is a function which itself may be or may not be linear. h is a variable for health. V is the 
K N×  matrix of independent variables and among which we have health aid. Suppose that 
we have two groups A (stable countries) and B (post conflict countries). 
The mean difference between A and B can be decomposed as follows: 
ˆ ˆ ˆ ˆ( ) ( ) ( ) (A B A A B A B A B Bh h F V F V F V F Vψ ψ ψ ψ   − = − + −    (3) 
Where ψˆ  is the estimated vector of coefficients from equation (2). The first component in 
bracket measures differences in observable characteristics (explained components) and the 
second component measures differences in coefficients (unexplained components). 
Following Even and Macpherson (1990; 1993), Yun (2005), the contribution of a variable k  
to health outcomes differential in explained component is given as follows: 
ˆ( )
ˆ ˆ( ) ( )
ˆ( )
k k k
A B A
k A B B B
A B A
V VC F V F V
V V
ψψ ψ
ψ
 
−
 = −   
− 
(4) 
Where kgV  is the mean of observations of the variable k  in the group g : A, B. ˆ
k
gψ  is the 
estimated coefficient of variable k  in group g .  
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3.2. Indirect effect of health aid in sub-Saharan African countries 
Any assessment of health aid effectiveness needs to identify the key channels through which 
aid may impact several health outcomes such as life expectancy, prevalence of HIV or infant 
mortality. In this vein, two main channels have been highlighted in the literature. 
 According to Schmidt (2009), Levine et al (2004), Mishra and Newhouse (2009), aid leads to 
improved outcomes in poor countries by reducing resource constraints and directly improving 
health service delivery. Specifically, aid leads to the increase of health spending and therefore 
an improvement of health outcomes. However, one should be cautious as regard to this 
channel. In fact, in poor countries, health aid constitutes a huge part of health spending 
(Williamson, 2008; Youde, 2010) due to lack of internal resources. Thus, health spending 
cannot be seen as a channel through which health aid may affect health outcomes.  
Besides, past studies indicate that health aid may be used to improve female literacy and 
consequently generalize the adoption of health best practice (Wagstaff, 2011; Mishra and 
Newhouse, 2009). It is this later channel which is tested in this paper. 
In order to evaluate the indirect effects of health aid, we rely upon the paper of Karlson et al 
(2010).10 This is a well known approach according to which the indirect effect of health aid on 
health outcomes is the difference between the total effect of health aid and the direct effect of 
health aid. The total effect of health aid is the one obtained when we run a simple regression 
of health aid on health outcomes. The direct effect is the one obtained when we control for a 
full set of potential explanatory variables. 
 
4. RESULTS 
 
In this section, we turn to the discussion of statistical and econometric results.  
4.1. Aid trend and health outcomes: some basic correlations 
A useful starting point is to examine the bivariate relationship between health aid and each 
health outcome.         
Figure 1 presents a combined graph of the correlation between health aid and each health 
outcome. The first graph in the up left side shows an intuitive positive correlation between 
health aid and life expectancy. The third graph in the down side shows a negative association 
between health aid and infant mortality. Finally, the second graph in the up right side exhibits 
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a counterintuitive positive correlation between health aid and the prevalence of HIV. This 
positive association likely reflects the endogeneity of aid, as more aid flows to countries 
where health indicators are deteriorating. 
 
Figure 1: basic correlation between health aid and selected health outcomes 
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The scatter plot is only suggestive, and the next subsection presents results from regression 
analysis that includes additional control variables. 
 
4.2. Health aid and health outcomes: some econometric results 
The main objective of this subsection is to present and discuss the results drawn from 
econometric analysis. Specifically, we discuss both observed direct and indirect effect of 
health aid on some health outcomes. 
4.2.1. Does health aid directly affect health outcomes in selected sub-Saharan African 
countries? 
Table 2 provides the OLS fixed effect estimates of the impact of health aid on respectively 
life expectancy, prevalence of HIV and infant mortality. According to this table, health aid 
has a positive and significant (at the 1% level) effect on life expectancy, while its influence is 
negative as regard to the prevalence of HIV. Especially, for each additional unit of health aid, 
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life expectancy increases by 0.03 while the prevalence of HIV decrease by 0.04. The effect of 
health aid on infant mortality is not significant.  
 
    [Insert Table 2 about here]  
 
To determine these results more accurately, an instrumental variable estimation is 
implemented to control for the potential endogeneity bias driving the effect of health aid. Let 
us recall that health aid is instrumented by the amount of aid weighted by indicators of 
geographical and linguistic proximity between the receiver and the main donors (see section 
2). The instrumental variable estimates are presented in table 3. The results confirm the 
previous observations. In fact, after taking into account the endogeneity, the effect of health 
aid remains significant. More specifically, for each additional unit of health aid, life 
expectancy increases by 0.14, prevalence of HIV decrease by 0.05 and infant mortality 
decrease by 0.17.  Furthermore, the respective values of  Cragg–Donald Wald Fisher statistics 
of weak identification are all above the Stock-Yogo critical values (Stock and Yogo, 2005), 
suggesting that the instrument chosen are not weak. In the same vein, the Hansen’s test for 
over-identifying restrictions does not reject the null hypothesis that the instruments used are 
not correlated with the residuals of the structural equation. The magnitude of the 2SLS 
estimates of the effect of health aid on health outcomes is higher than that of the OLS 
estimate. This is consistent with a positive correlation between the unobserved components of 
each health outcome measure and health aid. The increased magnitude of the 2SLS estimate 
relative to the OLS estimate could also be attributed to noise in the per capita health aid 
variable, which would attenuate the OLS estimates towards zero (Mishra and Newhouse, 
2009). Turning to other control variables, better governance improves health whatever the 
indicator chosen. This result is similar to that of Chauvet et al. (2008) and may find an 
explanation on the fact that in poor countries there is a huge lack of health infrastructure as 
regard to health demand and low ability to pay for health care services. Furthermore, GDP per 
capita is more likely to reduce infant mortality and the prevalence of HIV while they have no 
effect on life expectancy. This latter result is quietly surprising. However, this is a short run 
effect since improvement in health outputs implies some structural changes in health inputs 
(infrastructures, human capital, and governance) that only occur in the long run.  
 
     [Insert Table 3 about here] 
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Finally, both OLS and 2SLS estimates suggest that health aid in sub-SSA is effective in 
solving health issues. This is true for all the used indicators which are life expectancy, 
prevalence of HIV and infant mortality. 
In order to refine the analysis, we make a comparison between post conflict countries and 
stable ones. As stated earlier in the paper, this choice is in accordance with the idea that aid 
could be more effective in post conflict states than in stable one11. Before presenting the 
results of the Oaxaca-Blinder decomposition, the T-test of difference in sample mean is 
computed in order to assess whether there is a significant difference between post conflict 
states and stable states in terms of the amount of health aid per capita, life expectancy, 
prevalence of HIV and infant mortality. Table 4.1 displays the results. The main observation 
drawn from this table is that there is a significant difference (at the 1% level) between post 
conflict countries and stable countries in terms of both the amount of health aid received and 
health outcomes. Precisely, post conflict countries receive less aid than stable ones (3.4 USD 
per capita against 6.5 USD per capita) while they exhibit a higher rate of infant mortality 
(148/1000 against 120/1000). Besides, life expectancy is higher in stable states (53 years) than 
in post conflict states (50 years). On contrary, the results of the sample mean test show that 
the prevalence of HIV is higher in stable countries (7.17 %) than in post conflict ones 
(3.47%). Once this mere comparison has been done, it is useful to see whether the observed 
differences in the amount of health aid received can explain the observed differences in health 
outcomes. Table 4.2 gives an answer to this question as it presents the contribution of health 
aid to the health outcome gap between post conflict countries and stable countries. The first 
remark which can be made is that whatever the measure of health outcomes, differences in the 
amount of aid received do not explain differences in health outcomes12.  On the contrary, 
differences in terms of the primary completion rate for female and in terms of governance 
seem to be the main explanation of the differences in health outcomes.13 
 
     [Insert Table 4.1 & Table 4.2 about here] 
                                                           
11
 The reader may wonder why the paper does not make the comparison according to the level of governance. It 
is well established that post conflict countries are those who receive an important amount of aid during the early 
years following the conflict. Then it seems appropriate to assess its effectiveness in this specific context as 
regard to stable countries. 
12For the purpose of interpretation, let us underline that what is useful is the columns related to endowments, that 
is the contribution of the differences in explanatory variables (columns 2, 6, 10 and 14). Table 4.3 in appendix 
provides the results of an alternative approach based on a regression which control for conflict dummy. 
13
 However this result does not hold for the prevalence of HIV. 
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4.2.1. Does health aid indirectly affect health outcomes in selected sub-Saharan African 
countries? 
Table 5 shows the results of the estimation of the indirect effects of health aid on health 
outcomes. According to the relevant literature (Schmidt, 2009; Mishra and Newhouse, 2009), 
we test one main channel14: the primary completion rate for female. The results show that this 
channel is valid as regard to infant mortality and life expectancy. This suggests that investing 
the amount of health aid on the improvement of female education may be a way to improve 
health outcomes. Such an effect can operate through a better prevention and reduction of risk 
behavior.  
     [Insert Table 5 about here] 
 
5. ROBUSTNESS CHECK 
Three types of robustness check are implemented15.  
Following Williamson (2008), we make use of an alternative measure of health aid. For this 
purpose, the aid devoted to general health is chosen. This is described as aid allocated for 
health policy and administrative management; medical education/training; medical research 
and medical services. Data are from World Bank (ADI, 2011). Table 6.1 shows that the 
results still hold for life expectancy and the prevalence of HIV. However, one may notice that 
the magnitude of the effects is much higher. 
As a second robustness check, we account for non linearity by including the squared of health 
aid in the model. The results displayed in table 6.2 do not provide any evidence of a non 
linear relationship between health aid and respectively life expectancy and the prevalence of 
HIV. Nevertheless, this result can be explained by the short period of the study which does 
not permit to assess the long run effects of health aid. Yet, the results provide a support to the 
hypothesis of a non linear relationship between health aid and infant mortality. Specifically, 
above a threshold of 41US$ per capita, the effect of health aid diminish. The only country 
                                                           
14
 We discussed about the relevance of health expenditure as a channel in the section devoted to the 
methodology. 
15
 We also add fertility as an additional control. According to Kalemli-Ozcan & Turan (2011), there is a reverse 
causal relationship between fertility and health outcomes, notably, the prevalence of HIV. This is a way to 
address this issue. 
16 
 
which has reached this level is Namibia which records an amount of 44.24 US$ per capita of 
health aid. 
Finally, following Hadi (1992) and Mishra and Newhouse (2009), a regression is ran on an 
alternative sample excluding Namibia which exhibit an average of health aid that represents 
more than 10 times the mean of the amount received by the remaining countries in the sample. 
The results presented in table 6.3 shows that the main results are to some extent very sensitive 
to dropping these observations. In fact the effect of health aid is not longer significant as 
regard to the prevalence of HIV and infant mortality. 
     [Insert Table 6.3 about here] 
To summarize, we found a positive effect of aid in improving health outcomes in SSA 
countries. Moreover, the obtained results suggest that this effect operate mainly through the 
improvement of female primary completion rate. Besides, the results show that differences in 
the amount of aid received between post conflict states and stable states does not explain the 
observed health outcomes gap. 
 
 
6. CONCLUDING REMARKS 
Despite the long standing debate on the effectiveness of health aid, studies related to the 
effects of health aid on health outcomes are surprisingly very scarce. This paper adds to the 
existing literature by providing the evidence of health aid effectiveness using a sample of 28 
SSA countries over the period of 2000-2010. 
After factoring in the endogeneity, the obtained results suggest that health aid help improving 
health outcomes in sub SSA. More specifically, for each additional unit of health aid, life 
expectancy increases by 0.14, prevalence of HIV decrease by 0.05 and infant mortality 
decrease by 0.17. This effect is quite small as regard to what is needed to achieve the 
millennium development goals. Moreover, the results seem to be very sensitive to the amount 
of aid received. However, this study adds to microeconomic works and provides evidence that 
reinforces the common believe according to which health aid improve health outcomes in 
SSA countries which are the most vulnerable countries within the block of developing 
countries. Furthermore, the current study has been able to identify a valid channel through 
which health aid affect health outcomes. In other words, the estimate shows that at the sole 
exception of HIV prevalence, the female primary completion rate is the main channel through 
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which health aid affects health outcomes. Finally, the analysis indicates that differences in 
terms of the amount of health aid received do not explain the health outcomes gap between 
post conflict countries and stable countries. The relevant variables are governance and the 
female primary completion rate. 
Given the fact that  health aid improves the health of the citizens of SSA, one policy 
recommendation could be to encourage external funding from donor agencies and 
international organizations, and the policymakers receiving these aids must managed them 
accordingly and be accounted. Furthermore, health aid should be oriented toward sub sector 
that are relevant to achieve MDGs.  
To sum up, this paper has demonstrated that health aid matters in Sub Saharan african 
countries. Even though the magnitude of the effect is quietly small, the results are robust to 
various falsification tests. Moreover, as far as health aid suffer for under-reporting; our 
estimates are likely to underestimate the true effect of health aid mainly in the OLS 
specification. Besides, due to lack of data this study only provide a short term evidence on the 
effect of health aid on health outcomes in SSA. In this vein, an avenue for future research may 
focus on an improvement of identification strategy and the increase of the length of the period 
under analysis in order to be able to assess a long run effect of health aid in Africa. 
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APPENDIX 
Table 1: Descriptive statistics 
Variable Obs Mean Std. Dev. Min Max 
Life expectancy 92 52.43036 4.888486 42.85856 64.11217 
Prevalence of HIV 88 6.130682 7.307064 .2 26.3 
Infant mortality at birth 92 78.10217 18.16568 38.6 114 
Health aid per capita 92 4.177379 7.77335 .1441504 51.18747 
General health aid per capita 91 2.261319 4.001701 .0102973 24.95076 
GDP per capita 92 656.1136 930.389 109.1669 4015.086 
Gross fixed Capital formation 92 20.52117 6.86806 6.097673 59.72307 
School enrolment rate primary 92 92.3457 25.05032 39.38571 144.8676 
Female primary completion rate 82 48.1951 22.73648 16.8888 97.75262 
Lagged variable of fertility 92 5.321522 .9974156 3.019 7.421 
Urban population% total 92 32.81522 16.17466 8.78 82.9 
Inflation CPI 92 6.311129 6.119928 -5.3554 26.67495 
Labor force 92 53.31933 2.689961 48.57729 61.56084 
Composite index of governance 92 .5076966 .1373029 .2690155 .8897291 
Instrument 1 92 35.92705 73.90722 -19.97155 619.0123 
Instrument 2 92 28.82295 74.43278 -38.76798 631.3417 
Instrument 3 92 -.0031469 .0010753 -.0061496 -.001516 
Instrument 4 92 4.30876 1.552522 1.125351 8.606515 
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Table 2: Estimated effects of health aid on health outcomes, 2000-2010, OLS fixed effect 
  (1) (2) (3) 
Dependent variables Life expectancy Hiv prevalence Infant mortality 
Health aid per capita 0.0343** -0.0418*** 0.0228 
(0.0157) (0.00601) (0.0645) 
GDP per capita 0.00210 -0.00174*** -0.0203*** 
(0.00128) (0.000549) (0.00629) 
Gross fixed Capital formation 0.0375* -0.0140 -0.0567 
(0.0209) (0.0108) (0.0607) 
School enrolment rate primary 0.0125 -0.00588 0.00885 
(0.0223) (0.0108) (0.0813) 
Primary completion rate female 0.0499*** 0.00910 -0.228*** 
(0.0160) (0.00758) (0.0629) 
Urban population% total 0.400** 0.0197 -1.422 
(0.183) (0.0957) (0.868) 
Inflation CPI 0.0237** -0.00939 0.00591 
(0.0113) (0.00842) (0.0383) 
Labor force 0.0130 0.0524 -1.035 
(0.211) (0.190) (1.342) 
Composite index of governance 8.512** -2.579** -38.98*** 
(3.414) (1.102) (12.42) 
Constant 28.03** 6.554 224.4*** 
(11.77) (8.798) (71.93) 
Number of observations 147 140 147 
R-squared 0.765 0.525 0.752 
Prob>Chi2 [0.000] [0.000] [0.000] 
Number of countries 29 28 29 
Note: Robust standard errors in parentheses. *** p<0.01, ** p<0.05, * p<0.1. 
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Table 3: Estimated effects of health aid on health outcomes, 2000-2010, IV fixed effect 
  (1) (2) (3) 
Dependent variables Life expectancy Hiv prevalence Infant mortality 
Health aid per capita 0.145*** -0.0530*** -0.171* 
(0.0288) (0.0140) (0.0978) 
GDP per capita 0.000662 -0.00111*** -0.0251*** 
(0.000670) (0.000390) (0.00274) 
Gross fixed Capital formation 0.0210** -0.00703 -0.0203 
(0.00899) (0.00554) (0.0193) 
School enrolment rate primary 0.0237 0.00234 -0.130*** 
(0.0159) (0.00477) (0.0463) 
Primary completion rate female 0.0216 0.00457 -0.0675 
(0.0162) (0.00933) (0.0694) 
Urban population% total 0.351** 0.0513 -1.651** 
(0.150) (0.107) (0.613) 
Inflation CPI 0.0229*** -0.0131 -0.000121 
(0.00812) (0.00824) (0.0305) 
Labor force -0.163 -0.117 -0.0255 
(0.145) (0.117) (0.670) 
Composite index of governance 8.771*** -2.877* -18.26* 
(2.739) (1.556) (9.826) 
Number of observations 91 87 91 
Number of countries 27 26 27 
Number of excluded instruments 2 3 4 
F-test of aid instrumentation equation: P-value [0.000] [0.000] [0.000] 
F-test values  224.16  163.23  124.6 
Hansen OID test-p-value  0.39  0.28 0.18 
Note: Robust standard errors in parentheses. *** p<0.01, ** p<0.05, * p<0.1. The endogenous variable is health aid.  
The Cragg–Donald Wald F-stat. of weak identification are all above the Stock-Yogo weak ID test criticl values. 
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Table 4: Instrumentation equations, first step of IV estimation 
  (1) (2) (4) 
Dependent variables Health aid Health aid Health aid 
Instrument 1 0.0313** 0.0309** 0.0309** 
(0.0131) (0.0134) (0.0133) 
Instrument 2 -0.00663 -0.00643 -0.00663 
(0.0132) (0.0136) (0.0131) 
Instrument 3 128.4 135.2 
(195.4) (181.9) 
Instrument 4 0.0412 
(0.147) 
GDP per capita -0.00341 -0.00345 -0.00334 
(0.00249) (0.00254) (0.00283) 
Gross fixed Capital formation 0.00794 0.00817 0.00820 
(0.0226) (0.0224) (0.0217) 
School enrolment rate primary -0.00432 -0.00550 -0.00566 
(0.0349) (0.0354) (0.0355) 
Primary completion rate female 0.103* 0.102* 0.102* 
(0.0530) (0.0512) (0.0514) 
Urban population% total 0.166 0.181 0.148 
(0.285) (0.295) (0.353) 
Inflation CPI 0.0110 0.0157 0.0148 
(0.0251) (0.0207) (0.0202) 
Labor force 0.474 0.468 0.446 
(0.394) (0.385) (0.422) 
Composite index of governance -1.989 -2.009 -1.892 
(5.928) (6.188) (6.221) 
Constant -28.89 -28.53 -26.53 
(20.10) (19.69) (23.42) 
Observations 93 93 93 
R-squared 0.433 0.436 0.436 
Number of countries 29 29 29 
Note: Robust standard errors in parentheses. *** p<0.01, ** p<0.05, * p<0.1. Instruments are 
defined in appendix 
 
Table 4.1: T-test for difference in sample mean between post conflict states and stable states 
Variables Health aid Life expectancy HIV prevalence Infant mortality 
Post 
conflict Stable 
Post 
conflict Stable 
Post 
conflict Stable 
Post 
conflict Stable 
Mean 
 3.419502 6.684717 
 49.8465 
 
53.10571  3.470833 
 
7.015417  147.9477  120.0255 
Difference 3.265215 3.259217 3.544583  -27.92219 
T-statistic 3.7304 6.2832  6.7521  -7.9514 
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Table 4.2: Contribution of Health aid to the health outcome gap between post conflict states and stable states, 
  (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) 
 
Life expectancy Hiv prevalence Infant mortality at birth 
  Overall Endowments Coefficients Interaction Overall Endowments Coefficients Interaction Overall Endowments Coefficients Interaction 
Health aid per capita 
 
-0.569 0.751 1.054 
 
-0.523 0.0634 0.0845 
 
3.769 -3.216** -4.513 
  
(0.786) (0.471) (1.074) 
 
(0.638) (0.364) (0.490) 
 
(3.547) (1.349) (4.091) 
GDP per capita 
 
2.077 -3.035 -3.645 
 
-1.048 3.765** 3.713 
 
-12.99 11.92 14.32 
  
(3.714) (3.117) (4.224) 
 
(1.482) (1.902) (2.978) 
 
(11.10) (7.432) (11.78) 
Gross fixed Capital formation 
 
0.280 3.392 0.440 
 
-0.255 -4.239** -0.736 
 
-0.532 -9.439 -1.224 
  
(0.321) (2.192) (0.508) 
 
(0.231) (1.761) (0.685) 
 
(0.672) (8.243) (1.586) 
School enrolment rate primary 
 
-1.176 19.14*** 1.677 
 
0.205 -0.945 -0.0633 
 
2.856 -39.24** -3.437 
  
(1.377) (7.400) (2.012) 
 
(0.384) (6.364) (0.438) 
 
(3.350) (19.24) (4.252) 
Primary completion rate female 
 
4.207* -10.52** -5.155 
 
-0.580 4.943 2.202 
 
-16.45* 16.18 7.930 
  
(2.456) (5.053) (3.214) 
 
(0.761) (4.248) (2.150) 
 
(8.444) (13.33) (7.251) 
Urban population% total 
 
-0.881 6.075 1.455 
 
0.359 -11.92*** -1.788 
 
4.593 -16.40 -3.926 
  
(1.386) (5.246) (1.900) 
 
(0.649) (4.534) (2.940) 
 
(4.988) (10.000) (4.532) 
Inflation CPI 
 
0.118 -1.432 -0.191 
 
-0.106 1.398 0.672 
 
-0.223 3.038 0.406 
  
(0.266) (1.106) (0.450) 
 
(0.104) (0.872) (0.562) 
 
(0.506) (3.072) (0.991) 
Labor force 
 
0.619 0.763 0.0110 
 
-0.243 30.86 0.380 
 
-1.384 17.09 0.246 
  
(0.913) (38.82) (0.559) 
 
(0.452) (33.39) (0.792) 
 
(2.024) (87.71) (1.309) 
Composite index of governance 
 
3.866 -2.542 -1.521 
 
2.317 -4.941 -3.154 
 
-14.24* 12.63 7.555 
  
(2.832) (5.878) (3.523) 
 
(1.650) (4.622) (2.985) 
 
(8.167) (15.79) (9.512) 
Stable states 53.50*** 
   
7.718*** 
   
71.47*** 
   
 
(1.183) 
   
(2.020) 
   
(4.535) 
   Post conflict states 51.45*** 
   
4.157*** 
   
84.62*** 
   
 
(1.286) 
   
(0.531) 
   
(5.084) 
   difference 2.050 
   
3.561* 
   
-13.15* 
   
 
(1.747) 
   
(2.088) 
   
(6.813) 
   endowments 8.542** 
   
0.127 
   
-34.61** 
   
 
(3.863) 
   
(1.677) 
   
(14.80) 
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coefficients -0.615 
   
2.124 
   
4.099 
   
 
(2.257) 
   
(3.043) 
   
(5.298) 
   interaction -5.877 
   
1.309 
   
17.36 
   
 
(4.325) 
   
(3.936) 
   
(13.20) 
   Constant 
  
-13.21 
   
-16.86 
   
11.53 
 
   
(37.53) 
   
(31.25) 
   
(83.16) 
 Observations 150 150 150 150 143 143 143 143 150 150 150 150 
 
Table 5: Indirects effects of health aid on health outcomes 
  (1) (3) (5) 
Dependent variable Life expectancy Hiv prevalence Infant mortality at birth 
Total effect 0.0620*** -0.0425*** -0.0500 
(0.0188) (0.00995) (0.0754) 
Direct effect 0.0448** -0.0427*** 0.0168 
(0.0183) (0.00972) (0.0736) 
Indirect effect 0.0173** 0.000230 -0.0667** 
(0.00823) (0.00129) (0.0319) 
Transmission channel female primary completion rate  female primary completion rate  female primary completion rate  
Observations 149 141 149 
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Table 6.1: Robustness check, IV fixed effect, Changing the interest variable (health aid general)  
  (1) (2) (3) 
Dependent variables 
Life 
expectancy 
Hiv 
prevalence 
Infant mortality at 
birth 
Health aid general per capita 0.219*** -0.112*** -0.331 
(0.0634) (0.0327) (0.200) 
GDP per capita 0.000796 -0.00104*** -0.0256*** 
(0.000612) (0.000347) (0.00298) 
Gross fixed Capital formation 0.0174** -0.00854* -0.0155 
(0.00729) (0.00482) (0.0213) 
School enrolment rate primary 0.0249 -0.00289 -0.108** 
(0.0166) (0.00557) (0.0496) 
Lagged variable of fertility 0.00990 0.00479 -0.0856 
(0.0135) (0.00822) (0.0632) 
Primary completion rate female -3.203** -1.425 2.243 
(1.362) (0.850) (5.288) 
Urban population% total 0.185 -0.00835 -1.402* 
(0.153) (0.0908) (0.726) 
Inflation CPI 0.0166* -0.0107 0.00182 
(0.00880) (0.00706) (0.0331) 
Labor force -0.548** -0.281* 0.294 
(0.256) (0.143) (1.022) 
Composite index of governance 8.713** -1.167 -20.62* 
(3.254) (1.350) (11.23) 
Observations 90 86 90 
Number of countries 27 26 27 
Number of excluded instruments 2 3 4 
F-test of general health aid instrumentation 
equation  149.49 70.26 84.12 
Hansen OID test-p-value 0.98 0.16  0.11 
Note: Robust standard errors in parentheses. *** p<0.01, ** p<0.05, * p<0.1. The endogenous variable is 
health aid. The Cragg–Donald Wald F-stat. of weak identification are compared with the Stock-Yogo weak 
ID test critical values. [19.93 (10%); 11.59 (15%); 8.75 (20%); 7.25 (25%)] for (1) &(4), [9.08 (10%);  6.46 
(20%);  5.39 (25%)] for (2) & (3). 
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Table 6.2: Robustness check, IV fixed effect, accounting for non linearities 
  (1) (2) (3) 
Dependent variables Life expectancy Hiv prevalence Infant mortality at birth 
Health aid general per capita 0.272* -0.0527 -1.229** 
(0.152) (0.0813) (0.489) 
Health aid general per capita squared -0.00233 0.000393 0.0149* 
(0.00226) (0.00130) (0.00847) 
GDP per capita 0.00136 -0.000753 -0.0300*** 
(0.000837) (0.000475) (0.00461) 
Gross fixed Capital formation 0.0178*** -0.00569 -0.0318 
(0.00571) (0.00644) (0.0346) 
School enrolment rate primary 0.0172 0.00265 -0.0505 
(0.0142) (0.00482) (0.0421) 
Lagged variable of fertility 0.00983 0.00154 -0.00286 
(0.0161) (0.0114) (0.0838) 
Primary completion rate female -3.179** -1.012 8.745 
(1.175) (0.933) (5.731) 
Urban population% total 0.0794 -0.0692 -0.641 
(0.182) (0.111) (1.010) 
Inflation CPI 0.0115 -0.0116 0.0357 
(0.0100) (0.00905) (0.0367) 
Labor force -0.580** -0.207 1.815 
(0.235) (0.179) (1.265) 
Composite index of governance 8.987*** -2.687 -22.54* 
(2.473) (1.966) (11.05) 
Observations 91 87 91 
Number of countries 27 26 27 
Threshold of health 41.33637 US$ 
Number of countries above the threshold 1 
Number of excluded instruments 2 3 4 
F-test of excluded instruments  7.23  10.15  10.59 
Hansen OID test-p-value  0.62 0.08  0.54 
Note: Robust standard errors in parentheses. *** p<0.01, ** p<0.05, * p<0.1. The endogenous variable is health 
aid.  The Cragg–Donald Wald F-stat. of weak identification are compared with the Stock-Yogo weak ID test 
critical values. [19.93 (10%); 11.59 (15%); 8.75 (20%); 7.25 (25%)] for (1) &(4), [9.08 (10%);  6.46 (20%);  5.39 
(25%)] for (2) & (3). 
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Table 6.3: Robustness check, IV fixed effect, excluding ouliers (see Hadi,1992, 1994) 
  (1) (2) (3) 
Dependent variables Life expectancy Hiv prevalence Infant mortality at birth 
Health aid per capita 0.249** -0.0338 -0.447 
(0.119) (0.0461) (0.398) 
GDP per capita 0.00112 -0.000759 -0.0269*** 
(0.000851) (0.000455) (0.00391) 
Gross fixed Capital formation 0.0185*** -0.00609 -0.0187 
(0.00577) (0.00699) (0.0222) 
School enrolment rate primary 0.0187 0.000602 -0.0837* 
(0.0140) (0.00479) (0.0438) 
Primary completion rate female 0.00726 0.00276 -0.0902 
(0.0144) (0.00827) (0.0630) 
Lagged variable of fertility -2.880** -1.198 3.973 
(1.255) (1.008) (5.339) 
Urban population% total 0.151 -0.0736 -1.061 
(0.208) (0.105) (0.889) 
Inflation CPI 0.0131 -0.0134 0.0229 
(0.0102) (0.00853) (0.0373) 
Labor force -0.526** -0.235 0.599 
(0.246) (0.181) (1.169) 
Composite index of governance 8.974*** -2.555 -21.07** 
(2.447) (1.854) (9.249) 
Observations 88 84 88 
Number of countries 26 25 26 
Number of excluded instruments 2 3 4 
Instrument F-stat  7.9  8.00 6.40 
Hansen OID test-p-value  0.50 0.20  0.19 
Note: Robust standard errors in parentheses. *** p<0.01, ** p<0.05, * p<0.1. The endogenous variable is 
health aid.  The Cragg–Donald Wald F-stat. of weak identification are compared with the Stock-Yogo weak 
ID test critical values. [19.93 (10%); 11.59 (15%); 8.75 (20%); 7.25 (25%)] for (1) & (4), [9.08 (10%); 6.46 (20%); 5.39 
(25%)] for (2) & (3). 
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Table 7.a: List of countries according to the political situation 
Post conflict states Stable States    
Burundi Benin Madagascar  Swaziland 
Central African Republic Botswana Malawi Tanzania 
Chad Burkina Faso Mali Togo 
Congo, Rep. Cameroon Mauritania Zambia 
Ethiopia Gabon Mozambique 
Rwanda Gambia, The Namibia 
Sudan Ghana Niger 
Uganda Kenya Senegal 
  
 
   
Note: This is the minimum number of countries used for regressions 
Table 7.b: Countries  
Countries Number of observations 
Benin 4 
Botswana 4 
Burkina Faso 4 
Burundi 4 
Cameroon 3 
African Republic 2 
Chad 4 
Congo, Rep. 4 
Ethiopia 4 
Gabon 2 
Gambia, The 3 
Ghana 4 
Kenya 1 
Madagascar 4 
Malawi 2 
Mali 4 
Mauritania 2 
Mozambique 3 
Namibia 3 
Niger 4 
Rwanda 4 
Senegal 4 
Sudan 3 
Swaziland 4 
Tanzania 3 
Togo 3 
Uganda 4 
Zambia 2 
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Table 8: Composite Index of Governance, Principal Component Analysis 
Dimensions de la gouvernance Indice de qualité de la gouvernance 
Control of corruption 0.4217 
 (0.89) 
Rule of law 0.4367 
 (0.9295) 
Regulatory quality 0.4055 
 (0.86) 
Governance effectiveness 0.4284 
 (0.90) 
Political stability 0.3672 
(0.79) 
Voice and accountability 0.3856 
   (0.84) 
Note: We report the first eigenvector resulting from the first principal component analysis of 
governance quality. The aggregate index of governance is obtained using the following 
formula: Inst = 0.42*K1 + 0.43*K2 + 0.40*K3 + 0.428*K4 + 0.36*K5 + 0.38*K6, where K1, 
K2, K3, K4, K5, and K6 represent standardized measures of Control of corruption, Rule of 
law, Regulatory quality, Government effectiveness, Political stability, and Political stability, 
respectively. In addition, the numbers in parentheses (below the different eigenvectors) 
represent the the correlation of the first principal component with the corresponding 
governance variable. The governance quality variables have been rescaled so that high values 
indicate high level of bad governance. 
 
